| An unexpected N-terminal loop in PD-1 dominates binding by nivolumab S Tan, H Zhang, Y Chai, H Song, Z Tong, Q Wang, J Qi, G Wong, X Zhu, ... Nature communications 8 (1), 14369, 2017 | 246 | 2017 |
| B1 oligomerization regulates PML nuclear body biogenesis and leukemogenesis Y Li, X Ma, Z Chen, H Wu, P Wang, W Wu, N Cheng, L Zeng, H Zhang, ... Nature communications 10 (1), 3789, 2019 | 43 | 2019 |
| The FG loop of PD-1 serves as a “Hotspot” for therapeutic monoclonal antibodies in tumor immune checkpoint therapy D Chen, S Tan, H Zhang, H Wang, W He, R Shi, Z Tong, J Zhu, H Cheng, ... Iscience 14, 113-124, 2019 | 35 | 2019 |
| Structural basis of DUX4/IGH-driven transactivation X Dong, W Zhang, H Wu, J Huang, M Zhang, P Wang, H Zhang, Z Chen, ... Leukemia 32 (6), 1466-1476, 2018 | 26 | 2018 |
| Mitochondrial quality control in the brain: The physiological and pathological roles X Shen, P Sun, H Zhang, H Yang Frontiers in Neuroscience 16, 1075141, 2022 | 20 | 2022 |
| Functional, structural, and molecular characterizations of the leukemogenic driver MEF2D-HNRNPUL1 fusion M Zhang, H Zhang, Z Li, L Bai, Q Wang, J Li, M Jiang, Q Xue, N Cheng, ... Blood, The Journal of the American Society of Hematology 140 (12), 1390-1407, 2022 | 13 | 2022 |
| Phase separation is required for PML nuclear body biogenesis and function W Wu, Y Tan, H Yin, M Jiang, Y Jiang, X Ma, T Yin, Y Li, H Zhang, X Cai, ... The FASEB Journal 37 (6), e22986, 2023 | 8 | 2023 |
| DNA crosslinking and recombination‐activating genes 1/2 (RAG1/2) are required for oncogenic splicing in acute lymphoblastic leukemia H Zhang, N Cheng, Z Li, L Bai, C Fang, Y Li, W Zhang, X Dong, M Jiang, ... Cancer Communications 41 (11), 1116-1136, 2021 | 8 | 2021 |
| Transcription factor abnormalities in B-ALL leukemogenesis and treatment H Yin, J Wang, Y Tan, M Jiang, H Zhang, G Meng Trends in Cancer 9 (10), 855-870, 2023 | 7 | 2023 |
| DUX4HD2-DNAERG structure reveals new insight into DUX4-Responsive-Element X Dong, H Zhang, N Cheng, K Li, G Meng Leukemia 33 (2), 550-553, 2019 | 6 | 2019 |
| A typical bedside-to-bench investigation of leukemogenic driver MEF2D fusion reveals new targeted therapy in B-cell acute lymphoblastic leukemia H Zhang, G Meng Blood Science 4 (03), 161-163, 2022 | 3 | 2022 |
| Crystal structure of the GTP-binding protein-like domain of AGAP1 N Cheng, H Zhang, S Zhang, X Ma, G Meng Acta Crystallographica Section F: Structural Biology Communications 77 (4 …, 2021 | 3 | 2021 |
| Purification, crystallization, and X-ray diffraction analysis of myocyte enhancer factor 2D and DNA complex Z Chen, Q Wang, H Zhang, X Ma, W Wu, N Cheng, J Zhang, A Zhou, Y Li, ... Protein Expression and Purification 179, 105788, 2021 | 3 | 2021 |
| 埃博拉病毒入侵: 人 TIM 分子的结构与结合 PS 的分子基础 王寒， 齐建勋， 刘宁宁， 李燕， 高俊， 张廷虹， 柴彦， 高峰， 张浩， 李向东 科学通报, 3438-3453, 2015 | 3 | 2015 |
| Transcription factor 12‐mediated self‐feedback regulatory mechanism is required in DUX4 fusion leukaemia Z Li, M Jiang, J Wang, Z Zhuo, S Zhang, Y Tan, W Hu, H Zhang, G Meng Clinical and Translational Medicine 13 (12), e1514, 2023 | 1 | 2023 |
| De novo myelodysplastic syndrome in a Rothmund-Thomson Syndrome patient with novel pathogenic RECQL4 variants C Jiang, H Zhang, C Zhao, L Wang, X Hu, Z Pan Blood Science 5 (02), 125-130, 2023 | 1 | 2023 |
| Integrative genomics unveils basement membrane-related diagnostic markers and therapeutic targets in esophageal squamous cell carcinoma H Zhang, X Zhang, Z Huang, H Zhang Biology Direct 19 (1), 79, 2024 | | 2024 |
Guoyu Meng (蒙国宇）Professor in Hematology, Principal Investigator, Ruijin Hospital, Shanghai Jiaotong University在 shsmu.edu.cn 的电子邮件经过验证
